Admission Date:  [**2170-1-25**]              Discharge Date:   [**2170-2-6**]   Service: CARDIOTHORACIC  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 1505**] Chief Complaint: SOB  Major Surgical or Invasive Procedure: [**1-30**] AVR ([**First Name8 (NamePattern2) 17167**] [**First Name5 (NamePattern1) 923**] [**Last Name (NamePattern1) 9041**]), CABG x 1 (LIMA->LAD)   History of Present Illness: [**Age over 90 **] yo F with known AS, admitted to [**Hospital3 **] [**11-20**] and treated for pneumonia.
Past Medical History: HTN lipids hypothyroid s/p bilat lens transplant legally blind iron deficiency anemia s/p fall [**2164**] with ?
Family History: NC  Physical Exam: Preop VS HR 77 BP 140/73 RR 16 O2sat 94% on ra Neuro non focal- legally blind CV RRR 3/6 SEM rad to carotids Resp + rhonchi on R, CTA Left GI + BS, soft/NT/ND Extrem no edema, warm, well perfused, small amount chronic swelling over left malleolus Pulses Rad  Fem  [**Doctor Last Name **]  DP/PT R        2+   2+   1+   1+ L        2+   2+   1+   1+ Discharge VS T 97  HR 52AF  BP 115/55  RR 18  O2sat 94%RA Gen NAD Neuro A&Ox3, MAE, follows commands.
The patient is status post median sternotomy and CABG, as before.
DR. [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 4392**] Cardiology Report ECHO Study Date of [**2170-1-30**]    PATIENT/TEST INFORMATION: Indication: CAD, AS, AI, MR  Evaluate ventricular function, valve status, aortic atheroma intraop for CABG/AVR Height: (in) 59 Weight (lb): 137 BSA (m2): 1.57 m2 BP (mm Hg): 106/39 HR (bpm): 67 Status: Inpatient Date/Time: [**2170-1-30**] at 10:15 Test: TEE (Complete) Doppler: Full Doppler and color Doppler Contrast: None Tape Number: 2007AW2-: Test Location: Anesthesia West OR cardiac Technical Quality: Adequate     REFERRING DOCTOR: DR. [**First Name (STitle) **] R. [**Doctor Last Name **]  MEASUREMENTS: Left Atrium - Long Axis Dimension: *5.3 cm (nl <= 4.0 cm) Left Atrium - Four Chamber Length: *6.3 cm (nl <= 5.2 cm) Right Atrium - Four Chamber Length: *5.4 cm (nl <= 5.0 cm) Left Ventricle - Inferolateral Thickness: 0.8 cm (nl 0.6 - 1.1 cm) Left Ventricle - Diastolic Dimension: *6.0 cm (nl <= 5.6 cm) Left Ventricle - Systolic Dimension: 4.9 cm Left Ventricle - Fractional Shortening: *0.18 (nl >= 0.29) Left Ventricle - Ejection Fraction: 50% to 60% (nl >=55%) Left Ventricle - Peak Resting LVOT gradient: 3 mm Hg (nl <= 10 mm Hg) Aorta - Valve Level: 2.1 cm (nl <= 3.6 cm) Aorta - Ascending: 2.9 cm (nl <= 3.4 cm) Aorta - Arch: 2.7 cm (nl <= 3.0 cm) Aorta - Descending Thoracic: 2.0 cm (nl <= 2.5 cm) Aortic Valve - Peak Velocity: *3.0 m/sec (nl <= 2.0 m/sec) Aortic Valve - Peak Gradient: 36 mm Hg Aortic Valve - Mean Gradient: 19 mm Hg Aortic Valve - Valve Area: *0.9 cm2 (nl >= 3.0 cm2) Mitral Valve - Peak Velocity: 2.3 m/sec Mitral Valve - Mean Gradient: 12 mm Hg Mitral Valve - Pressure Half Time: 135 ms Mitral Valve - E Wave: 2.3 m/sec Mitral Valve - A Wave: 1.2 m/sec Mitral Valve - E/A Ratio: 1.92 Mitral Valve - E Wave Deceleration Time: 220 msec  INTERPRETATION:  Findings:  LEFT ATRIUM: Moderate LA enlargement.
The patient was under general anesthesia throughout the procedure.
Using Flow convergence/PISA techniques and pressure half time after replacement of the Aortic valve, the MVA is estimated to be between 1.3-1.7 cm2 (moderate MS).
POST-BYPASS: Patient is AV paced, on phenylepherine infusion.
A dental consult was called after her home dentist reported a broken tooth on last exam, and recommended perioperative coverage with antibiotics.
Penicillin was started.She remained in the hospital until she was taken to the operating room on [**2170-1-30**] where she underwent a AVR and CABG x1.She was extubated  and her vasoactive drips were weaned to off on POD #1.
She had several episodes of rate controlled atrial fibrillation for which she was anticoagulated with coumadin and started on amiodarone/metoprolol.
Medications on Admission: ASA 325' Diovan/HCTZ 320/12.5' FeSO4 325' Fosamax 70 q week Levoxyl 100' Lipitor 20' Lisinopril 20' Norvasc 5' Zetia 10' TUMS and Vit D 1500'   Discharge Medications: 1.
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Ranitidine HCl 150 mg Tablet Sig: One (1) Tablet PO once a day.
Aspirin 81 mg Tablet, Delayed Release (E.C.)
Ferrous Sulfate 325 (65) mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Levothyroxine 100 mcg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Atorvastatin 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Ezetimibe 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Tramadol 50 mg Tablet Sig: One (1) Tablet PO Q4-6H (every 4 to 6 hours) as needed.
Amiodarone 200 mg Tablet Sig: Two (2) Tablet PO once a day: 400 mg daily x 1 week, then 200 mg daily ongoing (until dc'd by cardiologist).
Penicillin V Potassium 250 mg Tablet Sig: One (1) Tablet PO Q6H (every 6 hours).
Warfarin 1 mg Tablet Sig: as directed Tablet PO DAILY (Daily): target INR 1.5-2.
Furosemide 40 mg Tablet Sig: One (1) Tablet PO BID (2 times a day): [**Hospital1 **] x 1 week then QD.
Metoprolol Tartrate 25 mg Tablet Sig: 0.5 Tablet PO BID (2 times a day).
Lisinopril 2.5 mg Tablet Sig: One (1) Tablet PO once a day.
Discharge Disposition: Extended Care  Facility: [**Location (un) 582**] - [**Location (un) 7658**]  Discharge Diagnosis: AS, CAD s/p AVR/CABG PMH: HTN lipids hypothyroid s/p bilat lens transplant legally blind iron deficiency anemia s/p fall [**2164**] with ?
Shower, no baths, no lotions, creams or powders to incisions.
Followup Instructions: Dr. [**Last Name (STitle) **] 4 weeks Dr [**Last Name (STitle) 71226**] 3-4 weeks Dr. [**Last Name (STitle) **] 2 weeks after discharge from rehabilitation    Completed by:[**2170-2-6**
